Fig 1A Ibrahim Elmadbouh Tadalafil suplement .tif (2.41 MB)View fileThis item contains files with download restrictions
IMAGE
Fig 1B Ibrahim Elmadbouh Tadalafil suplement.tif (144.27 kB)View fileThis item contains files with download restrictions
IMAGE
Fig 2 Ibrahim Elmadbouh Tadalafil suplement.tif (2.75 MB)View fileThis item contains files with download restrictions
IMAGE
Fig 3 Ibrahim Elmadbouh Tadalafil suplement.tif (2.94 MB)View fileThis item contains files with download restrictions
IMAGE
Fig 4 Ibrahim Elmadbouh Tadalafil suplement.tif (2.48 MB)View fileThis item contains files with download restrictions
IMAGE
Fig 5 Ibrahim Elmadbouh Tadalafil suplement.tif (3.08 MB)View fileThis item contains files with download restrictions
IMAGE
Fig 6 Ibrahim Elmadbouh Tadalafil suplement.tif (159.22 kB)View fileThis item contains files with download restrictions
Next page
Previous page
1/1
Switch ViewSwitch between different file views
Thumbnail viewList viewFile view
8 filesFullscreen
Dataset for: Tadalafil, a long acting phosphodiesterase inhibitor, promotes bone marrow stem cell survival and their homing into ischemic myocardium for cardiac repair
posted on 2017-11-15, 10:01authored byIbrahim Elmadbouh, Muhammad Ashraf
The aim was to evaluate the tadalafil-mediated effects at molecular level on bone marrow-derived mesenchymal stem cells (MSCs) survival and their homing into the infarcted hearts to promote cardiac repair and improve function. MSCs were pretreated in vitro with tadalafil (+/-H2O2, oxidative stress) and with PKG, MAPK, FasL, nitric oxide synthase (NOS) (L-NAME), CXCR4 (AMD3100), or miR-21 inhibitors (+/-luciferase construction +/-Fas) for 2h before tadalafil. Rats were subjected to acute myocardial infarction (AMI), and then followed by injection of saline or 1.5x106 MSCs-treated +/- tadalafil into infarcted area. In another group, AMI was performed in 1-month post-myelo-ablated rats, were injected intraperitoneally (IP) with tadalafil +/- AMD3100 or L-NAME for 5 days. Also, in another group, AMI mice were treated with IP +/- tadalafil before intravenous injection with 111In-oxine-MSCs followed by CT/SPECT imaging to locate mobilized MSCs. Cardiac function was assessed by echocardiography. MSCs and heart extracts were analyzed by molecular bioassays. Tadalafil-treated MSCs had higher expression of cGMP, NOS, SDF-1α, p-VASP, p-Erk1/2, p-STAT3, p-Akt, PKG1 and Bcl-xl; expression of these molecules was reduced with PKG1, MAPK, NOS or FasL inhibitors. Tadalafil inhibited apoptosis through increased miR-21 expression and improved cell survival by inhibiting Fas (restored by PKG1, MAPK or miR-21 inhibitors). In vivo, heart function, grafted cell survival, MSCs mobilization and homing were improved in tadalafil-treated AMI animals versus controls. Conclusions: Tadalafil prolonged MSCs survival via up-regulation of miR-21 dependent suppression of Fas, and increased MSCs mobilization and their homing into infarcted myocardium resulting in improved cardiac repair and function.